Ginkgo Bioworks Holdings (DNA) Other Operating Expenses (2020 - 2026)

Ginkgo Bioworks Holdings has reported Other Operating Expenses for 7 years, with the latest figure at -$7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 54.1% year-over-year to -$7.1 million; the trailing twelve-month figure through Mar 2026 stood at -$12.7 million (down 730.05% YoY), and the FY2025 full-year result was -$4.5 million, down 216.98% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$7.1 million, down from -$4.5 million in the prior quarter.
• The five-year high for Other Operating Expenses was $10.9 million in Q4 2024, with the low at -$7.1 million in Q1 2026.
• Historically, Other Operating Expenses has averaged $265882.4 across 5 years, with a median of $93000.0 in 2023.
• The largest YoY upside for Other Operating Expenses was 11602.15% in 2024 against a maximum downside of 342.41% in 2024.
• Ginkgo Bioworks Holdings' Other Operating Expenses stood at $6.2 million in 2022, then sank by 98.49% to $93000.0 in 2023, then jumped by 11602.15% to $10.9 million in 2024, then plunged by 141.6% to -$4.5 million in 2025, then tumbled by 57.87% to -$7.1 million in 2026.
• The last three Other Operating Expenses figures came in at -$7.1 million (Q1 2026), -$4.5 million (Q4 2025), and -$163000.0 (Q3 2025), per Business Quant data.